Skip to main content

Eurostars — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

68
Companies
$247.8M
Total invested
$4.0M
Avg. check
33
Industries
Biotechnology 12Health Care 9Medical 5Artificial Intelligence (AI) 5Pharmaceutical 5Software 4+27 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 68
Age Labs
December 2024

Age Labs is a molecular diagnostics company focused on reducing the cost of developing drugs by accurately measuring your biological age.

Biotechnology · OsloGrant
Wenemea
January 2026

Wenemea is the developer of chemotherapy-induced peripheral neuropathy designed for cancer treatment through neurological screening.

Medical · Aarhus$1.1M Grant
Simularge
December 2025

Plug & play autopilot for manufacturing machines with deep-tech AI ( Digital Twin, SaaS)

Artificial Intelligence (AI) · Palo Alto$117K Grant
Bio-Sourcing
January 2026

BioSourcing is developing a New Generation of Biotherapeutics, in particular Monoclonal Antibodies for Global Unmet Medical Needs

Biotechnology · LiègeGrant
WSK Medical
January 2025

First AI platform on the market for real-time detection and classification of Head and Neck cancers and benign lesions.

Artificial Intelligence (AI) · Amsterdam$168K Grant
Renalyse
October 2023

Renalyse is the registered trade name of CreatSens Health S.L., a biotechnology company focusing on the development of medical platforms.

Medical · Tarragona$1.1M Venture - Series Unknown
Magnes
October 2024

Magnes, has developed a disruptive real-life-monitoring solution to analyze walk patterns of patients with neurological disorders.

Consulting · ZürichGrant
Polar Light Technologies
March 2026

Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.

Lighting · LinköpingGrant
InVirtuoLabs
February 2026

InVirtuoLabs is a firm that uses artificial intelligence and molecular simulations to transform drug discovery.

Artificial Intelligence (AI) · Lugano$2.7M Grant
NEOGAP Therapeutics
February 2026

NEOGAP Therapeutics is a Pharmaceutical manufacturing industry.

Biotechnology · Stockholm$9.8M Series Unknown
ProVascTec
September 2025

ProVascTec is a preclinical stage cell treatment firm, to stimulate the development of a novel circulatory system.

Biotechnology · Cork$2.9M Grant
Sensars
September 2025

Sensars restores natural foot sensation in diabetics, preventing ulcers and amputations with neuromodulation.

Diabetes · West GroveSeed
INERGIO
September 2025

INERGIO is a reliable power power supply yet is a challenge to off-grid systems.

Environmental Consulting · LausanneGrant
Broken String Biosciences
July 2025

Broken String Biosciences is developing a platform of novel sequencing tools to assess genome stability and to unlock the next generation.

Biotechnology · CambridgeGrant
LenioBio
July 2025

LenioBio develops rapid plant-based, cell-free protein expression that scales for research, development and production.

Biotechnology · Düsseldorf$4.4M Grant
Cellevate
April 2025

Cellevate is an innovative biotech company that develops the next generation of cell culture systems.

Biotechnology · LundGrant
NOVIGENIX
March 2025

Novigenix is a precision medicine company that specializes in ImmunoTranscriptomic solutions.

Artificial Intelligence (AI) · Epalinges$1.9M Grant
Onena Medicines
March 2025

Onena Medicines is a biotechnology company provides medical devices, antibodies to treat cancer and rare diseases.

Biotechnology · Donostia-san SebastiánConvertible Note
bNovate Technologies
February 2025

BNovate Technologies develops automated water monitoring solutions, specializing in microbiological analysis through flow cytometry.

Biotechnology · Ecublens$4.2M Grant
Perciv AI
December 2024

Perciv offers AI based software solutions to unleash the hidden capabilities of radars and enable robust autonomous systems.

Artificial Intelligence (AI) · Delft$2.6M Seed
Brenus Pharma
September 2024

Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance.

Biotechnology · Issoire$25.0M Series A
Vandria
August 2024

Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders.

Manufacturing · Lausanne$10.1M Series A
Smart Reporting
April 2024

Smart Reporting is a digital health start-up that provides documentation software in the medical field.

Health Care · Munich$24.5M Series C
Hemotune
March 2024

Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.

Biotechnology · Schlieren$15.6M Series B

Where Eurostars invests

Biotechnology12
Health Care9
Medical5
Artificial Intelligence (AI)5
Pharmaceutical5
Software4

About Eurostars's portfolio

How many companies has Eurostars invested in?▸

Eurostars has invested in 68 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Eurostars invest in?▸

Eurostars's top investment sectors include Biotechnology, Health Care, Medical, Artificial Intelligence (AI), Pharmaceutical. The firm invests across 33 different industry categories.

What is Eurostars's largest investment?▸

Among tracked funding rounds, Brenus Pharma received $25.0M in a Series A round. Eurostars's total known invested capital is $247.8M.

What is the average investment size for Eurostars?▸

Eurostars's average investment size is $4.0M across its portfolio of 68 companies.

What are Eurostars's most recent investments?▸

Recent Eurostars portfolio additions include Age Labs, Wenemea, Simularge, Bio-Sourcing, WSK Medical. These companies were founded in 2020 or later.

Reach the founders behind these 68 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →